Onkos Surgical Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
105
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$37.2M
- Investors
-
8
Onkos Surgical General Information
Description
Manufacturer of precision orthopaedic implants designed for musculoskeletal oncology and complex reconstruction. The company's technology utilizes virtual surgical planning, 3D printing, and antibacterial coatings to provide patient-matched implants, extendible prostheses, and personalized instrumentation, enabling surgeons to implement precise reconstructions, reduce operative complexity, and address clinical challenges associated with tumor surgery and limb salvage.
Contact Information
Website
www.onkossurgical.comCorporate Office
- 77 East Halsey Road
- Parsippany, NJ 07054
- United States
Corporate Office
- 77 East Halsey Road
- Parsippany, NJ 07054
- United States
Onkos Surgical Timeline
Onkos Surgical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series C) | 07-Aug-2026 | $37.2M | Completed | Generating Revenue | ||
| 7. Debt - General | 30-Sep-2025 | Completed | Generating Revenue | |||
| 6. Debt - General | 08-Jan-2025 | Completed | Generating Revenue | |||
| 5. Debt - PPP | 29-Jan-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 07-Aug-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 16-Jul-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jun-2019 | $15.3M | Completed | Startup | ||
| 1. Early Stage VC (Series A) | 06-Oct-2015 | $15.3M | $15.3M | Completed | Startup |
Onkos Surgical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 10,200,000 | $0.001000 | 8% | $1 | $1 | 1x | $1 | 17% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Onkos Surgical Comparisons
Industry
Financing
Details
Onkos Surgical Competitors (4)
One of Onkos Surgical’s 4 competitors is Neotherix, a Accelerator/Incubator Backed company based in York, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neotherix | Accelerator/Incubator Backed | York, United Kingdom | ||||
| Intuitive | Formerly VC-backed | Sunnyvale, CA | ||||
| Lazarus 3D | Venture Capital-Backed | Philomath, OR | ||||
| Avelas Biosciences | Venture Capital-Backed | San Diego, CA |
Onkos Surgical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Onkos Surgical Patents
Onkos Surgical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260232877-A1 | Functionalized metallic implants with covalently bound polymer coatings for therapeutic agent association | Pending | 13-Feb-2025 | ||
| WO-2026174093-A1 | Functionalized metallic implants with covalently bound polymer coatings for therapeutic agent association | Pending | 13-Feb-2025 | ||
| US-12390333-B2 | Suture hole geometry and methods for attaching tissue to orthopedic implants | Active | 20-Nov-2020 | ||
| US-20220160510-A1 | Suture hole geometry and methods for attaching tissue to orthopedic implants | Active | 20-Nov-2020 | ||
| US-20250345177-A1 | Suture hole geometry and methods for attaching tissue to orthopedic implants | Pending | 20-Nov-2020 | A61F2/30771 |
Onkos Surgical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Onkos Surgical Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3D Ventures | Venture Capital | Minority | ||
| JSD Capital | Growth/Expansion | Minority | ||
| SV Health Investors | PE/Buyout | Minority | ||
| Canaan Partners | Venture Capital | Minority | ||
| Rocky Point Ventures | Family Office | Minority |
Onkos Surgical Investments (1)
Onkos Surgical’s most recent deal was a Corporate Asset Purchase with Stryker (Juvenile Tumor System). The deal was made on 03-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Stryker (Juvenile Tumor System) | 03-Jun-2022 | Corporate Asset Purchase | Surgical Devices |
Onkos Surgical FAQs
-
When was Onkos Surgical founded?
Onkos Surgical was founded in 2015.
-
Where is Onkos Surgical headquartered?
Onkos Surgical is headquartered in Parsippany, NJ.
-
What is the size of Onkos Surgical?
Onkos Surgical has 105 total employees.
-
What industry is Onkos Surgical in?
Onkos Surgical’s primary industry is Surgical Devices.
-
Is Onkos Surgical a private or public company?
Onkos Surgical is a Private company.
-
What is the current valuation of Onkos Surgical?
The current valuation of Onkos Surgical is .
-
What is Onkos Surgical’s current revenue?
The current revenue for Onkos Surgical is .
-
How much funding has Onkos Surgical raised over time?
Onkos Surgical has raised $125M.
-
Who are Onkos Surgical’s investors?
3D Ventures, JSD Capital, SV Health Investors, Canaan Partners, and Rocky Point Ventures are 5 of 8 investors who have invested in Onkos Surgical.
-
Who are Onkos Surgical’s competitors?
Neotherix, Intuitive, Lazarus 3D, and Avelas Biosciences are competitors of Onkos Surgical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
